Background and Objectives Dedifferentiated chondrosarcoma is a rare malignancy with
reported 5‐year overall survival rates ranging from 7% to 24%. The purpose of this …

Background Dedifferentiated chondrosarcoma (DCS) is a rare and aggressive malignancy
with a poor prognosis. The purpose of this investigation was to describe our treatment and …

Background. Dedifferentiated chondrosarcomas (DDCSs) are highly malignant tumors with
a dismal prognosis and present a significant challenge in clinical management. Methods. In …

Simple Summary Dedifferentiated chondrosarcoma (DDCS) is a rare cancer that is
aggressive and leads to high patient mortality. There are limited data on the efficacy of …

Abstract Purpose of Review The pathogenesis of dedifferentiated chondrosarcoma is
controversial, and no genetic abnormality has consistently been identified in the disease …

Background Dedifferentiated chondrosarcoma is a rare, highly malignant tumor with a poor
survival. There are many confusing issues concerning the imaging feature that can facilitate …

Background Dedifferentiated chondrosarcomas consist of two distinguishable components:
low-grade chondrosarcoma components and high-grade dedifferentiated components …

BACKGROUND: Dedifferentiated chondrosarcoma has a very poor prognosis. Because of
its rarity, there are few large studies of outcome which might identify potential prognostic …

Background: There are very few published data on the survival of patients with
dedifferentiated chondrosarcoma, or, more specifically, on the efficacy and role of …

Background: Dedifferentiated chondrosarcomas that arise in osteochondromas are
extremely rare lesions for which very little information on treatment and outcome is available …